Nelly Viseux | VP, Cell Therapies Development, Manufacturing, Supply & Quality
Regeneron

Nelly Viseux, VP, Cell Therapies Development, Manufacturing,  Supply & Quality, Regeneron

Development and manufacturing are where strategy is realized. Nelly Viseux is a biotechnology executive at Regeneron Pharmaceuticals leading cell therapy development, manufacturing, and CMC strategy. She has built and scaled internal capabilities enabling rapid IND readiness and reliable cGMP delivery. She focuses on bridging innovation and execution, bringing clarity and structure to complex therapeutic platforms.

Appearances:



Advanced Therapies USA 2026 - Day 2 @ 13:25

Manufacturing Innovation and Operational Excellence to Boost a Cell Therapy Development Engine

Advanced Therapies USA 2026 - Day 2 @ 14:05

Panel Discussion: Manufacturing Strategies: Decentralised Vs. Centralised Approaches for Cell Therapies

last published: 24/Jun/26 18:25 GMT

back to speakers

Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit

Matthew Belmoh
Matthew.Belmoh@terrapinn.com
+44 7301058795

 

To speak

Chris Shanks
chris.shanks@terrapinn.com
+02034332221